Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  cachexia (weight loss)
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-23 of 23 for your search:
Start Over
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069218, NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, SC18, NCT00031707
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000069417, NCCTG-N01C9, NCI-P02-0226, N01C9, NCT00040885
Phase III Randomized Adjuvant Preoperative Total Parenteral Nutrition in Patients Undergoing Surgery for Carcinoma of the Esophagus, Stomach, Pancreas, Colon, and Rectum
Phase: Phase III
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-103, NCI-T83-1089N, T83-1089
Phase III Double-Blind Randomized Study of CACP/VBL plus Hydrazine Sulfate vs Placebo in Patients with Advanced non-Small Cell Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-8931, CALGB-8931
Phase III Randomized Comparison of Hydrazine Sulfate vs Placebo in Patients with Advanced non-Small Cell Lung Cancer Receiving CACP/VP-16
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-892451, NCCTG-89-24-51
Phase III Randomized Study of Megestrol Acetate vs Fluoxymesterone vs Dexamethasone for the Treatment of Cancer-Related and Cancer Treatment-Related Anorexia and Cachexia
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-919252, MAYO-919252, NCI-P92-0004
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257027, NCCTG-N00C1, NCI-P02-0232, MC00C8, 1497-00, N00C1, NCT00046904
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0122, CDR0000269100, NCT00053053
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000360798, NCCTG-N02C4, N02C4, NCT00081250
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068329, CCCWFU-97300, CCCWFU-0009, CCCWFU-BG00-228, NCI-P00-0174, NCT00006799
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000069226, CCCWFU-98199, NCI-P02-0210, NCT00031785
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065766, CLB-9473, NCI-P97-0097, CALGB-9473, NCT00003077
Phase II Randomized Pilot Study of Pentoxifylline vs Placebo for Anorexia and Cachexia in Patients with Metastatic Malignancies (Summary Last Modified 03/98)
Phase: Phase II
Type: Supportive care
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9327, NCI-P94-0058
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: NU FDA98CC6, NU-98CC6, NCI-G00-1705, NCT00004912
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 2 to 20
Sponsor: NCI, Other
Protocol IDs: SCUSF 0205, HLMCC-0205, U10CA081920, MCC-0205, NCT00066248
Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068522, DMS-0005, ATP-DMS-0005, NCI-G01-1923, NCT00014248
Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: LCCC 0523, CDR0000549772, UNC-LCCC-0523, NCT00486304
Randomized Study of Megestrol as an Appetite Stimulant in Children With Cancer-Related Cachexia (Summary Last Modified 02/2002)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Under 21
Sponsor: NCI
Protocol IDs: MCC-0004, NCI-3990, NCI-P02-0202
Placebo-Controlled Evaluation of Megestrol Acetate in the Treatment of Cancer-Related Anorexia and Cachexia
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-889251, MAYO-889251
Dose-Response Evaluation of Megestrol to Treat Anorexia and Cachexia in Patients with Cancer
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-899255, MAYO-899255, NCI-P90-0009
Dose-Response Evaluation of Megestrol to Treat Cachexia in Patients with Advanced Lung or Colorectal Cancer (Summary Last Modified 12/92)
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: over 16
Sponsor: NCI
Protocol IDs: CLB-8971, NCI-P90-0012
Start Over